Smart prosthetics market seen reaching $3.18 billion by 2030

The smart prosthetics market is projected to grow from $2.03 billion in 2025 to $2.23 billion in 2026, driven by rising limb loss, AI-enabled devices and wider access through online sales. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through 2030.

Why it matters: - Smart prosthetics are moving from niche devices to a larger mobility market as patients, clinics and manufacturers adopt systems that improve control, comfort and independence. - The market’s projected rise to $3.18 billion by 2030 signals continued demand for advanced limb replacement technology. - The growth outlook matters most for people with limb loss tied to injury, disease or congenital conditions, especially as diabetes-related amputations continue to drive need.

What happened: - The Business Research Company released a smart prosthetics market intelligence report on Aug. 30, 2026. - The report puts the market at $2.03 billion in 2025 and $2.23 billion in 2026. - The report forecasts the market will reach $3.18 billion by 2030. - The report says North America held the largest market share in 2025. - The report says Asia-Pacific is expected to grow fastest through the forecast period.

The details: - Smart prosthetics use microprocessors and, in many cases, artificial intelligence to mimic natural movement and improve responsiveness. - The devices can detect muscle signals and adjust during activity. - The report links near-term market growth to limits in traditional prosthetics, ongoing use of mechanical limbs, growth in orthopedic clinics, higher awareness of mobility aids and early adoption by rehabilitation centers. - Forecast growth is tied to bionic and hybrid prosthetic advances, AI and sensor-based systems, more pediatric use, an aging population and wider direct and online sales channels. - Key trends include more microprocessor-controlled prosthetics, improved sensor-based movement recognition, growing use of myoelectric and hybrid models, expansion in rehabilitation services and more personalized solutions for children and adults. - The report says rising limb loss is a major growth driver. - Limb loss can result from injury, disease or congenital conditions. - Diabetes-related complications such as peripheral artery disease and neuropathic ulcers are increasing lower-limb amputations. - In December 2024, the Archives of Rehabilitation Research and Clinical Translation reported that about 2,309,000 people in the U.S. live with limb loss. - The same report said about 91% of those cases involve lower-extremity amputations and 9.2% involve upper-extremity amputations. - The limb-loss population is expected to rise by 145% by 2060. - The report says additional growth is coming from better prosthetic technology, more specialized rehabilitation and orthopedic clinics, and easier access through online sales channels. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 report package adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables. - The report includes a free sample and a full report download on the company’s website: Download a free sample and View the full report.

Between the lines: - The report points to a market that is being pulled by both medical need and product improvement. - North America’s lead suggests mature adoption, while Asia-Pacific’s faster growth suggests room for expansion as healthcare investment and orthopedic capacity increase. - The emphasis on online sales and personalization suggests vendors are trying to lower barriers to access and broaden use beyond a narrow patient base.

What's next: - The market is expected to keep expanding as AI, sensors and bionic features become more common in prosthetic design. - Growth should also track with aging populations, pediatric adoption and broader rehabilitation access. - Regional competition may intensify as Asia-Pacific adds healthcare investment and facilities while North America stays the largest market.